JHX LAWSUIT DEADLINE: Hagens Berman Urges James Hardie Investors to Act by Dec. 23 in Suit Over 34% Plunge Due to Inventory Destocking

JHX LAWSUIT DEADLINE: Hagens Berman Urges James Hardie Investors to Act by Dec. 23 in Suit Over 34% Plunge Due to Inventory Destocking Firm Investigating Alleged Undisclosed Sales Practices and CFO Departure After North America Fiber Cement Sales Collapse GlobeNewswire December 02, 2025 SAN FRANCISCO, Dec. 02, 2025 (GLOBE NEWSWIRE) — National shareholder rights law […]

Quantum Dynamics Enterprises, Inc. Engages Forge Global to Facilitate $2.5 Million Raise for CID(TM) Propulsion System

Key West, FL , Dec. 02, 2025 (GLOBE NEWSWIRE) — Quantum Dynamics Enterprises, Inc. (QDE), developer of the patented Centrifugal Impulse Drive (CID(TM)) — the world's first independently validated mechanical propellant-less propulsion system — has engaged Forge Global, Inc. to act as placement agent for a $2.5 million private equity raise, representing 500,000 shares at

RZOLV Technologies Inc. Announces Management Changes

Vancouver, British Columbia–(Newsfile Corp. – December 2, 2025) – RZOLV Technologies Inc. (TSXV: RZL) (“RZOLV” or the “Company”) is pleased to announce the appointment of Mark Orsmond as Chief Financial Officer (“CFO”), effective December 1, 2025. Mr. Orsmond is a seasoned Business and Finance executive with more than 25 years of proven success in leading, scaling, and transforming

Quantum Dynamics Enterprises, Inc. Engages Forge Global to Facilitate $2.5 Million Raise for CID(TM) Propulsion System

Quantum Dynamics Enterprises, Inc. Engages Forge Global to Facilitate $2.5 Million Raise for CID(TM) Propulsion System Funding to support orbital demonstration of the world's first mechanically driven, propellant-less satellite propulsion technology GlobeNewswire December 02, 2025 Key West, FL , Dec. 02, 2025 (GLOBE NEWSWIRE) — Quantum Dynamics Enterprises, Inc. (QDE), developer of the patented Centrifugal

Chamelo Introduces Next-Generation Fashion Frames Blending Smart Tint, Premium Audio, and Modern Style

NEW YORK, Dec. 02, 2025 (GLOBE NEWSWIRE) — Chamelo, the brand shaping a new era of smart eyewear through state-of-the-art technology and modern style, today announces the launch of Infinity and Zurix – two fashion-forward frames that elevate tint-adjustable eyewear with intuitive control, premium audio, and bold design. Created for the fashion-minded and tech-curious, these

Great Hearts Announces New Arizona Campus Opening in Fall 2027

Great Hearts Blossom Rock, opening Fall 2027, will bring nationally recognized, tuition-free classical education to the East Valley. https://mma.prnewswire.com/media/2836959/Great_Hearts_Arizona_Logo.jpg Located in the community of Blossom Rock, near Eastmark, Great Hearts Blossom Rockwill become Great Hearts 25th academy in Arizona, and welcome students in kindergarten through the elementary grades, with the potential to grow into upper

Chamelo Introduces Next-Generation Fashion Frames Blending Smart Tint, Premium Audio, and Modern Style

Chamelo Introduces Next-Generation Fashion Frames Blending Smart Tint, Premium Audio, and Modern Style Infinity & Zurix redefine what the eyewear experience should be GlobeNewswire December 02, 2025 NEW YORK, Dec. 02, 2025 (GLOBE NEWSWIRE) — Chamelo, the brand shaping a new era of smart eyewear through state-of-the-art technology and modern style, today announces the launch

New Data Presented at the Clinical Trials on Alzheimer’s Disease (CTAD) Conference 2025 Confirms Pharmacological Effect of LEQEMBI® (lecanemab-irmb) on Neurotoxic AB Protofibrils in CSF

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that the latest data confirming the pharmacological effect of lecanemab (generic name, U.S. brand name: LEQEMBI®), an anti-AB protofibril* antibody,on AB protofibrils (PF) in cerebrospinal fluid (CSF) was presented at

Corbin Advisors Advances Growth Strategy

Appoints Michael Becker as Vice President, Head of Sales & Marketing, unifying global business development and brand strategy to accelerate growth and deepen client impact FARMINGTON, Conn., Dec. 02, 2025 (GLOBE NEWSWIRE) — Corbin Advisors, a leading strategic investor relations and investor communications advisory firm, today announced the promotion of Michael Becker to Vice President,

New Data Presented at the Clinical Trials on Alzheimer’s Disease (CTAD) Conference 2025 Confirms Pharmacological Effect of LEQEMBI(R) (lecanemab-irmb) on Neurotoxic AB Protofibrils in CSF

(NASDAQ:BIIB), TOKYO and CAMBRIDGE, Mass., Dec. 02, 2025 (GLOBE NEWSWIRE) — Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that the latest data confirming the pharmacological effect of lecanemab (generic name, U.S. brand name: LEQEMBI(R)), an anti-AB protofibril*

Scroll to Top